Accelerating the pace of discovery.
Our Scientific Advisory Board is a network of more than 25 world-renowned researchers and clinicians, including eight Nobel Prize-winning scientists, who guide the direction of our company.
Eight winners of the Nobel Prize in Chemistry, Economic Sciences, and Physiology or Medicine since 1993, in areas of research including neuroscience, complex chemical systems, and biochemistry.
Science and Medicine Pioneers
Leaders in their fields, from gut health and cardiology to genomics and machine learning.
How We Work Together
Our board guides the scientific direction of Elysium. Its members are leaders in science and technology, pioneering a better approach to health. Rather than endorsing a specific product, this network of scientists, clinicians and health professionals advises the Elysium team on product identification and development, clinical studies, and ongoing research.
Our team is constantly reviewing — and in many cases, authoring — the most compelling scientific literature available today related to aging and proactive health. The board advises Elysium on pursuing research, designing clinical trials, and translating that work into products that can have the greatest impact on health.
Elysium’s board members participate in various fields of study, including biochemistry, neuroscience, and aging; others work as regulatory officials, clinicians, and investors. The scope of their expertise provides Elysium with the resources to research and build effective health products.
Our board's collaboration with top academic institutions provides us with access to intellectual property, the ability to partner on clinical trials, and connections to top researchers.